- In February 2025, XRHealth, a leading provider of therapeutic Extended Reality (XR) solutions, announced its acquisition of RealizedCare, a digital therapeutics company. This strategic move aims to create the largest AI-driven therapeutic XR platform globally, integrating RealizedCare's evidence-based methods for chronic pain and behavioral health, including a new AI triage tool to optimize personalized patient care
- In January 2025, various industry reports highlighted OxfordVR as a top-rated behavioral health technology vendor for 2025, recognized for client satisfaction and innovation. This underscores the increasing recognition and adoption of specialized VR solutions for mental health conditions within the broader behavioral health IT landscape
- In December 2024, the US government, through a new bill (Home-Based Tele-mental Health Care Act of 2023), and the Centers for Medicare and Medicaid Services (CMS) approved new reimbursement codes for FDA-cleared digital mental health therapies. This development significantly boosts the accessibility and adoption of digital therapeutics, including VR-based solutions, by improving reimbursement pathways for providers
- In September 2024, AppliedVR announced that its flagship VR device for chronic low back pain treatment, RelieVRx, became in-network for Highmark members. This partnership represents a significant step towards broader insurance coverage and validates the efficacy of VR as a non-pharmacological treatment for chronic conditions that often have psychological components
- In April 2023, XRHealth also completed the acquisition of Amelia Virtual Care (formerly Psious), a VR platform specifically designed for mental health professionals. This acquisition further expanded XRHealth's capabilities and market reach in providing flexible virtual reality software for diverse mental health therapeutic applications
